Lucid Diagnostics Inc. Earnings Per Share (Diluted)
Lucid Diagnostics Inc. (LUCD) reported Earnings Per Share (Diluted) of -$0.10 per share for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2025-11-12
- Lucid Diagnostics Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.10.
- Lucid Diagnostics Inc. earnings per share, diluted for the quarter ending 2025-06-30 was -$0.08.
- Lucid Diagnostics Inc. earnings per share, diluted for the quarter ending 2025-03-31 was -$0.52.
- Lucid Diagnostics Inc. earnings per share, diluted for the quarter ending 2024-12-31 was -$0.20.
- Lucid Diagnostics Inc. earnings per share, diluted for fiscal 2024 was -$1.05.
- Lucid Diagnostics Inc. earnings per share, diluted for fiscal 2023 was -$1.26.
- Lucid Diagnostics Inc. earnings per share, diluted for fiscal 2022 was -$1.55.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$0.10 10-Q · filed 2025-11-12 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.59 10-Q · filed 2025-11-12 | -$0.64 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-06-30 | -$0.08 10-Q · filed 2025-08-12 | -$0.52 10-Q · filed 2025-08-12 | -$0.57 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$0.80 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-03-31 | -$0.52 10-Q · filed 2025-05-13 | -$0.60 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$0.86 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$1.10 derived: net income ÷ weighted average shares · filed 2026-05-13 |
| 2024-12-31 | -$0.20 derived: net income ÷ weighted average shares · filed 2026-03-25 | -$0.44 derived: net income ÷ weighted average shares · filed 2026-03-25 | -$0.67 derived: net income ÷ weighted average shares · filed 2026-03-25 | -$1.05 10-K · filed 2025-03-24 |
| 2024-09-30 | -$0.25 10-Q · filed 2025-11-12 | -$0.47 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.87 10-Q · filed 2025-11-12 | -$0.96 derived: net income ÷ weighted average shares · filed 2025-11-12 |
| 2024-06-30 | -$0.23 10-Q · filed 2025-08-12 | -$0.62 10-Q · filed 2025-08-12 | -$0.72 derived: net income ÷ weighted average shares · filed 2025-08-12 | -$1.05 derived: net income ÷ weighted average shares · filed 2025-08-12 |
| 2024-03-31 | -$0.40 10-Q · filed 2025-05-13 | -$0.49 derived: net income ÷ weighted average shares · filed 2025-05-13 | -$0.83 derived: net income ÷ weighted average shares · filed 2025-05-13 | -$1.10 derived: net income ÷ weighted average shares · filed 2025-05-13 |
| 2023-12-31 | -$0.26 derived: net income ÷ weighted average shares · filed 2025-03-24 | -$0.59 derived: net income ÷ weighted average shares · filed 2025-03-24 | -$0.87 derived: net income ÷ weighted average shares · filed 2025-03-24 | -$1.26 10-K · filed 2025-03-24 |
| 2023-09-30 | -$0.34 10-Q · filed 2024-11-12 | -$0.61 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.01 10-Q · filed 2024-11-12 | -$1.40 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2023-06-30 | -$0.27 10-Q · filed 2024-08-12 | -$0.67 10-Q · filed 2024-08-12 | -$1.06 derived: net income ÷ weighted average shares · filed 2024-08-12 | -$1.45 derived: net income ÷ weighted average shares · filed 2024-08-12 |
| 2023-03-31 | -$0.40 10-Q · filed 2024-05-13 | -$0.80 derived: net income ÷ weighted average shares · filed 2024-05-13 | -$1.19 derived: net income ÷ weighted average shares · filed 2024-05-13 | -$1.60 derived: net income ÷ weighted average shares · filed 2024-05-13 |
| 2022-12-31 | -$0.40 derived: net income ÷ weighted average shares · filed 2024-03-25 | -$0.79 derived: net income ÷ weighted average shares · filed 2024-03-25 | -$1.20 derived: net income ÷ weighted average shares · filed 2024-03-25 | -$1.55 10-K · filed 2024-03-25 |
| 2022-09-30 | -$0.39 10-Q · filed 2023-11-13 | -$0.80 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$1.15 10-Q · filed 2023-11-13 | |
| 2022-06-30 | -$0.41 10-Q · filed 2023-08-14 | -$0.76 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |